Glyn Edwards talks about cancer drug development at Antisoma. Interview by Ulrike Knies-Bamforth and Dan Huke.
We're an exclusively oncology development-focused company; we've put together a portfolio of projects, which are rather different from each other, which is our way of diversifying the systemic risk out of the portfolio.